biotech · Respiratory Distress Syndrome · Cardiogenic Shock · WINT
WINDTREE THERAPEUTICS INC
WINDTREE THERAPEUTICS INC /DE/
WINDTREE THERAPEUTICS INC trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
2600 Kelly Rd., Suite 100, Warrington, PA 18976, US HQ
1992 Founded
17 Employees
Public company Type
WINT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2600 Kelly Rd., Suite 100, Warrington, PA 18976, US
- Founded
- 1992
- Employees
- 17
- Programs
- 15
- Drugs
- 9
- Patents
- 4
WINDTREE THERAPEUTICS INC clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to WINDTREE THERAPEUTICS INC programs — each row shows trial ID, program name, phase, status, and indication.
WINDTREE THERAPEUTICS INC trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for WINDTREE THERAPEUTICS INC.
-
Istaroxime, LActose — Phase 2
Clinical update -
Lucinactant for Inhalation — Phase 2
Clinical update -
Lucinactant for inhalation — Phase 2
Clinical update -
Lucinactant — Phase 2
Clinical update -
A.1 Lucinactant — Phase 2
Clinical update -
Placebo — Phase 2
Clinical update -
Istaroxime — Phase 2
Clinical update -
Rostafuroxin — Phase 2
Clinical update